04/20/16 - 10:10 AM EDT
Efforts by insurers to negotiate higher discounts or rebates on specialty pharmaceutical products isn't keeping pace with the price increases pushed through by drug and biotech companies, an analyst says.
04/20/16 - 08:31 AM EDT
Bluebird is trying to use a gene therapy to correct the rare and fatal genetic defect found in boys with CALD.
04/18/16 - 08:46 AM EDT
Chiasma shares are plunging Monday following the U.S. Food and Drug Administration rejection of the company's drug to treat acromegaly, a rare disease of the pituitary gland.
04/17/16 - 05:17 PM EDT
Six patients, all with TRK fusion cancers unresponsive to current therapies, reported tumor shrinkage following treatment with Loxo's drug LOXO-101.
04/15/16 - 06:00 AM EDT
TheStreet's Adam Feuerstein answers reader questions about biotech investing. There were a high number of emails on the upcoming Sarepta FDA advisory panel.
04/14/16 - 07:50 AM EDT
Chiasma is expecting the U.S. Food and Drug Administration to make an approval decision Friday on a new oral treatment for acromegaly, a rare disease of the pituitary gland.
04/12/16 - 01:51 PM EDT
An FDA advisory committee delivers a brutal beatdown of Clovis' lung cancer drug rociletinib. It could cost Clovis' CEO his job.
04/12/16 - 12:21 PM EDT
Investors give the side eye to a prediction from Chardan analyst Gbola Amusa that Amicus Therapeutics will be acquired for three times its current market value
04/12/16 - 07:00 AM EDT
Too many investors have a fundamental misunderstanding about the significance of orphan drug designation. I should say, insignificance, because the FDA delineation, on its own, means very little.
04/11/16 - 01:11 PM EDT
Shares of Endo fall as much as 9% Monday in sympathy with Insys Therapeutics, which pre-announced sharply weaker first-quarter sales of its fentanyl painkiller Subsys.